Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model
about
BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis.A novel multikinase inhibitor R8 exhibits potent inhibition on cancer cells through both apoptosis and autophagic cell death.Role of bevacizumab in the management of the patient with malignant pleural effusion: more questions than answers.Pharmacokinetic Considerations for Antibody-Drug Conjugates against Cancer.Mathematical modeling of intraperitoneal drug delivery: simulation of drug distribution in a single tumor nodule.Anti-angiogenic therapy affects the relationship between tumor vascular structure and function: A correlation study between micro-computed tomography angiography and dynamic contrast enhanced MRI.Intravoxel incoherent motion MR imaging of early cervical carcinoma: correlation between imaging parameters and tumor-stroma ratio.Cancer: Towards a general theory of the target: All successful cancer therapies, actual or potential, are reducible to either (or both) of two fundamental strategies.
P2860
Q35870363-9C024F75-446E-4722-9EAD-41BC8AB9820DQ44869860-264DC89D-793A-418B-82D4-DEFFB6BF8782Q47654289-D9C3897E-9095-4472-A538-FBE4CDEDD611Q47661007-67D3BC3D-CB96-4113-B320-340A46D469EFQ47978622-A3506F3D-7860-4275-BED4-9D8E43C15F95Q48196734-69693A1F-7622-4514-8C76-6E12D84A8A4EQ49986679-F233428F-8097-444E-8617-5D6CD86E432BQ51823888-3B444764-5B4F-4070-838C-57EF5F446BA2
P2860
Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Pretreatment with VEGF(R)-inhi ...... olorectal carcinomatosis model
@ast
Pretreatment with VEGF(R)-inhi ...... olorectal carcinomatosis model
@en
type
label
Pretreatment with VEGF(R)-inhi ...... olorectal carcinomatosis model
@ast
Pretreatment with VEGF(R)-inhi ...... olorectal carcinomatosis model
@en
prefLabel
Pretreatment with VEGF(R)-inhi ...... olorectal carcinomatosis model
@ast
Pretreatment with VEGF(R)-inhi ...... olorectal carcinomatosis model
@en
P2093
P2860
P356
P1433
P1476
Pretreatment with VEGF(R)-inhi ...... olorectal carcinomatosis model
@en
P2093
Andrei Izmer
Benedicte Descamps
Christian Vanhove
Félix Gremonprez
Olivier De Wever
Wim Ceelen
P2860
P304
29889-29900
P356
10.18632/ONCOTARGET.5092
P407
P577
2015-09-07T00:00:00Z